These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18539200)

  • 1. Pharmacogenomics and outcome of asthma: no clinical application for long-term steroid effects by CRHR1 polymorphisms.
    Dijkstra A; Koppelman GH; Vonk JM; Bruinenberg M; Schouten JP; Postma DS
    J Allergy Clin Immunol; 2008 Jun; 121(6):1510-3. PubMed ID: 18539200
    [No Abstract]   [Full Text] [Related]  

  • 2. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids.
    Tantisira KG; Lake S; Silverman ES; Palmer LJ; Lazarus R; Silverman EK; Liggett SB; Gelfand EW; Rosenwasser LJ; Richter B; Israel E; Wechsler M; Gabriel S; Altshuler D; Lander E; Drazen J; Weiss ST
    Hum Mol Genet; 2004 Jul; 13(13):1353-9. PubMed ID: 15128701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics and the variability of treatment response in asthma.
    Israel E
    J Allergy Clin Immunol; 2005 Apr; 115(4 Suppl):S532-8. PubMed ID: 15806036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of response to asthma controller therapy: clinical implications.
    Langmack EL; Martin RJ
    Curr Opin Pulm Med; 2010 Jan; 16(1):13-8. PubMed ID: 19875959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD.
    Kim WJ; Sheen SS; Kim TH; Huh JW; Lee JH; Kim EK; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Oh YM; Lee SD
    Respirology; 2009 Mar; 14(2):260-3. PubMed ID: 19210659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of anti-inflammatory treatment in children with asthma: rationale and design of the PACMAN cohort.
    Koster ES; Raaijmakers JA; Koppelman GH; Postma DS; van der Ent CK; Koenderman L; Bracke M; Maitland-van der Zee AH
    Pharmacogenomics; 2009 Aug; 10(8):1351-61. PubMed ID: 19663678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stepping-down inhaled corticosteroid therapy in stable asthma: a secondary care perspective.
    Lee DK; Borade PS; Promnitz DA; Currie GP
    QJM; 2005 Oct; 98(10):771-2. PubMed ID: 16170204
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of clinical practices in asthma].
    Gaga M
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S31-10S33. PubMed ID: 17127959
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on the management of asthma.
    Prussin C; Metcalfe DD
    Adv Intern Med; 2001; 46():31-50. PubMed ID: 11147258
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug trials.
    Adelroth E; Barnes NC; Chung KF; Davies RJ; Poulter LW
    Eur Respir J Suppl; 1998 Mar; 26():36S-38S. PubMed ID: 9585879
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of mild asthma.
    Raghupathy A; Brashier B; Salvi S
    N Engl J Med; 2005 Jul; 353(4):424-7; author reply 424-7. PubMed ID: 16050057
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problems in the inhalation corticosteroid therapy of bronchial asthma patients].
    Stepanian IE
    Ter Arkh; 1997; 69(8):60-2. PubMed ID: 9381396
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of mild asthma.
    Jenkins CR; Marks GB; Reddel HK
    N Engl J Med; 2005 Jul; 353(4):424-7; author reply 424-7. PubMed ID: 16050058
    [No Abstract]   [Full Text] [Related]  

  • 14. When oral corticosteroids are essential for persistent severe asthma.
    Greenberger PA
    J Allergy Clin Immunol; 2010 Feb; 125(2):511-3. PubMed ID: 20159270
    [No Abstract]   [Full Text] [Related]  

  • 15. Reducing asthma treatment.
    Chen R
    N Engl J Med; 2007 Aug; 357(5):504; author reply 505-6. PubMed ID: 17674455
    [No Abstract]   [Full Text] [Related]  

  • 16. Do the benefits of daily inhaled steroid treatment of mild asthma outweigh the risks?
    Pedersen S
    Arch Dis Child; 2008 Aug; 93(8):644-5. PubMed ID: 18644931
    [No Abstract]   [Full Text] [Related]  

  • 17. What does potency actually mean for inhaled corticosteroids?
    Williams DM
    J Asthma; 2005; 42(6):409-17. PubMed ID: 16293535
    [No Abstract]   [Full Text] [Related]  

  • 18. Home therapy with subcutaneous anti-immunoglobulin-E antibody omalizumab in 25 patients with immunoglobulin-E-mediated (allergic) asthma.
    Liebhaber M; Dyer Z
    J Asthma; 2007 Apr; 44(3):195-6. PubMed ID: 17454337
    [No Abstract]   [Full Text] [Related]  

  • 19. [Improvement of compliance in the therapy of asthma--what about evidence and how can the effect be evaluated?].
    Petro W
    Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S394-7. PubMed ID: 19941244
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fast-acting combinations of inhalable corticoids and long-acting beta2-sympathomimetics as long-term therapy of bronchial asthma. Opinions of an expert group. R. Buhl et al. Pneumology 53 (1999) 210-212].
    Gillissen A; Schultze-Werninghaus G
    Pneumologie; 1999 Dec; 53(12):M103-4. PubMed ID: 10684244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.